Diet: Clinical Trials

34 trials of Diet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 unknown, 2 not yet recruiting, 2 recruiting. 34 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 434Completed 21, Unknown 6, Not yet recruiting 2, Recruiting 2, Terminated 2, Active not recruiting 1

Follow Diet: new trials by email Literature Review of Diet trials Research Report on Diet

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease
Alginate, Magaldrate, Sucralfate - Laryngopharyngeal Reflux Disease
Phase 4Not yet recruitingUniversity of Mons8002026-05-012026-05-28
GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
Guselkumab, Diet - Pouchitis
Phase 4RecruitingUniversitaire Ziekenhuizen KU Leuven202026-04-232026-05-05
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
Efsubaglutide Alfa Injection, Diet and exercise guidelines - Obesity, Weight Loss
Phase 4RecruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School602025-09-162026-01-27
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Aspirin, Shexiang Baoxin Pill - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
Phase 4Not yet recruitingShanghai Hutchison Pharmaceuticals Limited95882025-09-012025-09-04
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
Semaglutide in combination with a healthy lifestyle intervention (diet and exercise) - Obesity and Obesity-related Medical Conditions, Psychiatric Disorders
Phase 4Active not recruitingSt Andrew's Healthcare202025-01-012026-04-28
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Liraglutide injection, Diet and exercise guidelines - Obesity, Weight Loss
Phase 4CompletedThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1002023-09-012026-01-28
Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.
omega-3 fatty acids, anthocyanins and alpha-cyclodextrins, diet, placebo - Gestational Diabetes, Oxidative Stress
Phase 4TerminatedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico512018-05-012022-05-26
Effect of Dietary Modifacation on Microbiota in Overweight and Obese Polycystic Ovary Syndrome Patients
Dietary and life style modification and probiotic Sanprobi Super Formula, Placebo - PCOS
Phase 4UnknownPoznan University of Medical Sciences802017-05-202017-10-30
SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.
Empagliflozin, Diet, Placebo - Diabetes Mellitus, Type 2
Phase 4CompletedUniversity of Leicester682016-12-012020-01-30
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy
Enteral nutrition, Oral nutrition - Pancreatic Cancer, Cancer of the Duodenum
Phase 4UnknownMedical University of Warsaw962016-11-012016-11-23
CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
Continuous positive airway pressure, Pharmacological treatment, Diet - Diabetic Nephropathy, Sleep Apnea
Phase 4CompletedHospital Universitario La Paz1802016-06-012021-05-11
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
insulin glargine, metformin, Forxiga - Type 2 Diabetes Mellitus
Phase 4CompletedPopulation Health Research Institute1542015-12-012020-11-24
Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents
Vitamin D supplementation, Placebo, 3 months lifestyle and dietary management - Obesity
Phase 4CompletedCentre Hospitalier Universitaire de Nīmes492015-03-302025-11-19
Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk
Diet - Renal Failure Chronic Contrast Induced
Phase 4CompletedUniversity of Cologne802013-07-012019-08-09
Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
Ritmonutra, placebo - Ventricular and Atrial Extrasytoles
Phase 4CompletedFederico II University15002012-12-012016-02-03
Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
Liraglutide, Diet and Exercise - Binge Eating Behaviour
Phase 4CompletedUniversiti Kebangsaan Malaysia Medical Centre422012-11-012017-05-04
Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss
Adjustable gastric banding, Dietary and lifestyle modification - Obesity, Diabetes
Phase 4CompletedMayo Clinic292010-10-012013-05-10
Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men
Exercise and diet - Sexual Dysfunction, Endothelial Dysfunction
Phase 4CompletedChangi General Hospital702010-07-012015-07-29
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
Paricalcitol, Calcitriol, Cholecalciferol - Cardiorenal Syndrome, Chronic Allograft Nephropathy
Phase 4CompletedUral State Medical University1092009-10-012015-06-09
Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.
Diet - Non-Alcoholic Fatty Liver Disease, Obesity
Phase 4CompletedUniversity of Hohenheim122009-08-152018-02-23

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Obesity (11)  ·  Diabetes Mellitus (4)  ·  Diabetes Mellitus, Type 2 (4)  ·  Hypertension (3)  ·  Insulin Resistance (3)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Sleep Apnea Syndromes (2)  ·  Weight Loss (2)  ·  Albuminuria (1)  ·  Arrhythmias, Cardiac (1)  ·  Binge-Eating Disorder (1)  ·  Cardio-Renal Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Cholangiocarcinoma (1)  ·  Coronary Disease (1)

Sponsors

Azienda Policlinico Umberto I (2)  ·  Mayo Clinic (2)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2)  ·  Aristotle University Of Thessaloniki (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Changi General Hospital (1)  ·  Collège National des Généralistes Enseignants (1)  ·  Federico II University (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Hospital Universitario La Paz (1)  ·  Istituto Auxologico Italiano (1)  ·  Janssen-Cilag Pty Ltd (1)  ·  Medical University of Warsaw (1)  ·  Mitsukoshi Health and Welfare Foundation (1)  ·  Population Health Research Institute (1)

Countries

Italy (6)  ·  United States (4)  ·  China (3)  ·  Belgium (2)  ·  France (2)  ·  Poland (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Greece (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Singapore (1)

Top investigators

Adrian Vella, MD (2)  ·  Alberto Zanchetti, MD (1)  ·  Alexander Kharlamov, M.D. (1)  ·  Alexander Perrish, M.D. (1)  ·  Antonia Perez Martin, MD, PhD (1)  ·  Brent A Tetri, MD (1)  ·  Bruno Trimarco, MD (1)  ·  Dimitrios Panidis, PhD (1)  ·  Enrico Ferrazzi, Professor (1)  ·  Francisco Garcia-Rio, MD (1)  ·  Haruo Nakamura, MD (1)  ·  Hertzel C Gerstein, MD (1)

Results publications

PMID 17011942, PMID 18172039, PMID 19053049, PMID 19104004, PMID 19423108, PMID 20498621, PMID 21593784, PMID 21689421, PMID 21815708, PMID 22573644, PMID 22839442, PMID 23250357, PMID 23635309, PMID 24083783, PMID 24843520, PMID 25135178, PMID 25870084, PMID 26246321, PMID 27178974, PMID 32403130, PMID 34050763, PMID 34090775, PMID 35441435, PMID 36342964, PMID 38018702, PMID 39636391, PMID 41364787

NIH funding

2015 (1), R01DK078646 (1), R01DK082396 (1), R01HL034659 (1), UL1RR024150 (1)